Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes. In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time. Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors. We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compound, R848. We detected direct binding of antimalarials to nucleic acids by spectroscopic experiments and determined their cellular colocalization. Further analysis revealed that other nucleic acid-binding compounds, such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes. We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials. In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition. We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compounds in the treatment…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Kuznik et al., 2011
In the citing paper
“Hydroxychloroquine (HCQ) is an approved anti-malaria drug, and accumulation of hydroxychloroquine inhibits the binding ability of TLR9 to DNA and subsequent immune activation (77).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [77]
Citations
Cites
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Research works printed but not linked: 2
- Ahmad-Nejad, 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · DOI · Paper page
- Peacocke, 1973, Acridines, 723
Cited by
Items 201–300 of 627
Huang, L., Stuart, C. E., Takeda, K., D’Agnillo, F., & Golding, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160875 · Cited by 45
Dietary N‐Glycans from Bovine Lactoferrin and TLR Modulation
Figueroa‐Lozano, S., Valk‐Weeber, R. L., van Leeuwen, S. S., Dijkhuizen, L., & de Vos, P. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700389 · Cited by 43
Ellegård, R., Crisci, E., Burgener, A., Sjöwall, C., Birse, K., Westmacott, G., Hinkula, J., Lifson, J. D., & Larsson, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401781 · Cited by 43
Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
Mackern‐Oberti, J. P., Llanos, C., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2015) · Immunology · doi:10.1111/imm.12504 · Cited by 42
Chloroquine and Hydroxychloroquine Toxicity
Song, W., Muste, J. C., Greenlee, T. E., & Singh, R. P. (2020) · American Journal of Ophthalmic Clinical Trials · doi:10.25259/ajoct_2_2020 · Cited by 42
von Stuckrad, A. S. L., Klotsche, J., Biesen, R., Lieber, M., Thumfart, J., Meisel, C., Unterwalder, N., & Kallinich, T. (2020) · Lupus · doi:10.1177/0961203320965699 · Cited by 42
Cénac, C., Ducatez, M., & Guéry, J. (2021) · European Journal of Immunology · doi:10.1002/eji.202149361 · Cited by 43
Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy
Yang, Y.-Z., Liu, L., Shi, S., Wang, J., Chen, Y., Lv, J., & Zhang, H. (2018) · American Journal of Nephrology · doi:10.1159/000487330 · Cited by 43
Hydroxychloroquine in nephrology: current status and future directions
Rao, I. R., Kolakemar, A., Shenoy, S. V., Prabhu, R., Nagaraju, S. P., Rangaswamy, D., & Bhojaraja, M. V. (2023) · Journal of Nephrology · doi:10.1007/s40620-023-01733-6 · Cited by 44
Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
Rizzo, C., Grasso, G., Castaniti, G. M. D., Ciccia, F., & Guggino, G. (2020) · Vaccines · doi:10.3390/vaccines8020272 · Cited by 40
Infante, M., Ricordi, C., Alejandro, R., Caprio, M., & Fabbri, A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1799785 · Cited by 44
The role of autophagy in the pathogenesis of systemic lupus erythematosus
Liu, X., Qin, H., & Xu, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.09.017 · Cited by 39
Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
Kalliolias, G. D., Basdra, E. K., & Papavassiliou, A. G. (2024) · Biomedicines · doi:10.3390/biomedicines12010138 · Cited by 44
Hornung, T., & Wenzel, J. (2014) · Drugs · doi:10.1007/s40265-014-0240-6 · Cited by 39
Bishayi, B., & Dey, S. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s76045 · Cited by 45
Collet, J. W., Ackermans, K., Lambregts, J., Maes, B. U. W., Orrù, R. V. A., & Ruijter, E. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02844 · Cited by 38
Lepse, N., Land, J., Rutgers, A., Kallenberg, C. G. M., Stegeman, C. A., Abdulahad, W. H., & Heeringa, P. (2015) · Rheumatology · doi:10.1093/rheumatology/kev293 · Cited by 37
van der Heijden, E. H. M., Hartgring, S. A. Y., Kruize, A. A., Radstake, T. R. D. J., & van Roon, J. A. G. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1624527 · Cited by 37
Tang, C., Lv, J., Shi, S., Chen, Y., Liu, L., & Zhang, H. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-00988-1 · Cited by 37
Hydroxychloroquine affects bone resorption both in vitro and in vivo
Both, T., Zillikens, M. C., Schreuders‐Koedam, M., Vis, M., Lam, W., Weel, A. E. A. M., van Leeuwen, J. P. T. M., van Hagen, P. M., van der Eerden, B. C. J., & van Daele, P. L. A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26028 · Cited by 37
The enigma of the clandestine association between chloroquine and HIV ‐1 infection
Chauhan, A., & Tikoo, A. (2015) · HIV Medicine · doi:10.1111/hiv.12295 · Cited by 36
KALUNIAN, K. C. (2016) · Lupus · doi:10.1177/0961203316652495 · Cited by 36
Ngo, Q. V., Faass, L., Sähr, A., Hildebrand, D., Eigenbrod, T., Heeg, K. M., & Nurjadi, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828626 · Cited by 40
Innate immune processes in lupus erythematosus
Aringer, M., Günther, C., & Lee‐Kirsch, M. A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.11.012 · Cited by 37
Bonegio, R. G. B., Lin, J. D., Beaudette-Zlatanova, B. C., York, M. R., Menn‐Josephy, H., & Yasuda, K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800300 · Cited by 37
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little, A. J., & Vesely, M. D. (2020) · PubMed Central · Cited by 51
Carrière, F., Longhi, S., & Record, M. (2020) · Biochimie · doi:10.1016/j.biochi.2020.05.013 · Cited by 36
Uludağ, G., Onghanseng, N., Tran, A. N. T., Hassan, M., Halim, M. S., Sepah, Y. J., Diana, V., & Nguyen, Q. D. (2021) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-021-00240-8 · Cited by 35
Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
Mamtimin, M., Pinarci, A., Han, C., Braun, A., Anders, H., Gudermann, T. W., & Mammadova‐Bach, E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869706 · Cited by 39
Hydroxychloroquine in IgA nephropathy: a systematic review
Stefan, G., & Mircescu, G. (2021) · Renal Failure · doi:10.1080/0886022x.2021.2000875 · Cited by 35
Alves, P., Bashir, M. M., Wysocka, M., Zeidi, M., Feng, R., & Werth, V. P. (2017) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1016/j.jisp.2016.11.001 · Cited by 35
Systemic lupus erythematosus: review of synthetic drugs
Tsang-A-Sjoe, M. W. P., & Bultink, I. E. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1101448 · Cited by 35
Hartman, O., Kovanen, P. T., Lehtonen, J. Y. A., Eklund, K. K., & Sinisalo, J. P. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw035 · Cited by 41
Pasquier, É., Martin, L. D. S., Marhic, G., Chauleur, C., Bohec, C., Bretelle, F., Lejeune, V., Hannigsberg, J., Plu‐Bureau, G., Cogulet, V., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025649 · Cited by 36
Lai, C.-Y., Yeh, D., Lu, C.-H., Liu, Y., Huang, L.-R., Kao, C., Chen, H., Huang, C. F., Chang, C., Luo, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500194 · Cited by 33
de Jong, T. D., Lübbers, J., Turk, S. A., Vosslamber, S., Mantel, E., Bontkes, H. J., van der Laken, C. J., Bijlsma, J. W. J., van Schaardenburg, D., & Verweij, C. L. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1065-3 · Cited by 33
Baruah, P., Bullenkamp, J., Wilson, P., Lee, M., Kaski, J. C., & Dumitriu, I. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01644 · Cited by 35
A 44‐year‐old man with eye, kidney, and brain dysfunction
Vodopivec, I., Oakley, D. H., Perugino, C. A., Venna, N., Hedley‐Whyte, E. T., & Stone, J. H. (2015) · Annals of Neurology · doi:10.1002/ana.24583 · Cited by 32
Schülke, S., Fiedler, A. H., Junker, A., Flaczyk, A., Wolfheimer, S., Wangorsch, A., Heinz, A., Beckert, H., Nagl, B., Bohle, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.002 · Cited by 34
Bodewes, I. L. A., & Versnel, M. A. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1519396 · Cited by 34
Small-molecule inhibitors and the salivary gland epithelium in Sjögren’s syndrome
Pringle, S., Wang, X., Bootsma, H., Spijkervet, F., Vissink, A., & Kroese, F. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1631796 · Cited by 30
Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?
Santos‐Sierra, S. (2021) · Biomolecules · doi:10.3390/biom11091291 · Cited by 35
Liu, J., Li, S., Fei, X., Nan, X., Shen, Y., Xiu, H., Cormier, S. A., Lu, C., Guo, C., Wang, S., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1965421 · Cited by 34
Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
Nakamura, T., Isoda, N., Sakoda, Y., & Harashima, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.046 · Cited by 32
Selvapandiyan, A., Puri, N., Kumar, P., Alam, A., Ehtesham, N. Z., Griffin, G. E., & Hasnain, S. E. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac041 · Cited by 34
Dysregulation of antiviral helicase pathways in systemic lupus erythematosus
Oliveira, L., Sinicato, N., Postal, M., Appenzeller, S., & Niewold, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00418 · Cited by 32
Saxena, M., Busca, A., Pandey, S., Kryworuchko, M., & Kumar, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100115 · Cited by 31
de Jong, T. D., Blits, M., de Ridder, S., Vosslamber, S., Wolbink, G., Nurmohamed, M. T., & Verweij, C. L. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1191-y · Cited by 31
Knöpfel, T. F., Nimsgern, P., Jacquier, S., Bourrel, M., Vangrevelinghe, E., Glatthar, R., Behnke, D., Alper, P. B., Michellys, P., Deane, J. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00130 · Cited by 31
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Sanctis, J. B. D., Charris, J., Blanco, Z., Ramírez, H., Martinez, G. P., & Mijares, M. R. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220519102948 · Cited by 36
Treatment of preeclampsia with hydroxychloroquine: a review
Rahman, R. A., DeKoninck, P. L. J., Murthi, P., & Wallace, E. M. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1289511 · Cited by 32
The Immunopathology of Cutaneous Lupus Erythematosus
Kirchhof, M. G., & Dutz, J. P. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.006 · Cited by 30
Treatment of systemic lupus erythematosus
McKeon, K., & Jiang, S. (2020) · Australian Prescriber · doi:10.18773/austprescr.2020.022 · Cited by 35
Ulander, L., Tolppanen, H., Hartman, O., Rissanen, T. T., Paakkanen, R., Kuusisto, J. K., Anttonen, O. M., Nieminen, T. V. M., Yrjölä, J., Ryysy, R., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.04.062 · Cited by 30
Endotracheal intubation results in acute tracheal damage induced by mtDNA/TLR9/NF-κB activity
Puyo, C. A., Earhart, A., Staten, N. R., Prince, O. A., Haug, C., Kollef, M. H., & Awad, M. M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5a0718-254rr · Cited by 31
Vincent, F. B., Bourke, P., Morand, E. F., Mackay, F., & Bossingham, D. (2012) · Internal Medicine Journal · doi:10.1111/imj.12039 · Cited by 29
Rhinovirus has the unique ability to directly activate human T cells in vitro
Ilarraza, R., Wu, Y., Skappak, C. D., Ajamian, F., Proud, D., & Adamko, D. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.041 · Cited by 29
Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats
McCarthy, C. G., Wenceslau, C. F., Goulopoulou, S., Baban, B., Matsumoto, T., & Webb, R. C. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw113 · Cited by 30
Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review
Choudhary, J., Dheeman, S., Sharma, V. K., Katiyar, P., Karn, S. K., Sarangi, M. K., Chauhan, A. K., Verma, G., & Baliyan, N. (2021) · Biological Procedures Online · doi:10.1186/s12575-020-00141-5 · Cited by 29
Ajamian, F., Wu, Y., Ebeling, C., Ilarraza, R., Odemuyiwa, S. O., Moqbel, R., & Adamko, D. J. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12498 · Cited by 28
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update
Pal, A., Pawar, A. T., Goswami, K., Sharma, P., & Prasad, R. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00900-x · Cited by 27
Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells
Kim, M. L., Hardy, M. Y., Edgington‐Mitchell, L. E., Ramarathinam, S. H., Chung, S. Z., Russell, A. K., Currie, I., Sleebs, B. E., Purcell, A. W., Tye–Din, J. A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103509 · Cited by 29
PKR and TLR3 trigger distinct signals that coordinate the induction of antiviral apoptosis
Zuo, W., Wakimoto, M., Kozaiwa, N., Shirasaka, Y., Oh, S.-W., Fujiwara, S., Miyachi, H., Kogure, A., Kato, H., & Fujita, T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05101-3 · Cited by 30
Clancy, R. M., Markham, A. J., Reed, J. H., Blumenberg, M., Halushka, M. K., & Buyon, J. P. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.09.003 · Cited by 30
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer
Tuomela, J. M., Sandholm, J. A., Kauppila, J. H., Lehenkari, P. P., Harris, K. W., & Selander, K. S. (2013) · Oncology Letters · doi:10.3892/ol.2013.1602 · Cited by 27
Goldfarb, I. T., Adeli, S., Berk, T., & Phillippe, M. (2017) · Reproductive Sciences · doi:10.1177/1933719117728798 · Cited by 27
Alopecia areata treated with hydroxychloroquine: A retrospective study of nine pediatric cases
Yun, D., Silverberg, N. B., & Stein, S. L. (2018) · Pediatric Dermatology · doi:10.1111/pde.13451 · Cited by 27
Tsubata, T. (2019) · Immune Network · doi:10.4110/in.2019.19.e1 · Cited by 29
Rahman, R. A., Murthi, P., Singh, H., Gurungsinghe, S., Leaw, B., Mockler, J. C., Lim, R., & Wallace, E. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072504 · Cited by 29
Pandey, R. P., Nascimento, M. S., Franco, C. H., Bortoluci, K. R., Silva, M. N., Zingales, B. S., Gibaldi, D., Barrios, L. C., Lannes-Vieira, J., Cariste, L. M., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-22 · Cited by 30
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
Delbaere, Q., Chapet, N., Huet, F., Delmas, C., Mewton, N., Prunier, F., Angoulvant, D., & Roubille, F. (2023) · Pharmaceuticals · doi:10.3390/ph16010078 · Cited by 31
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors
Amagai, R., Takahashi, T., Terui, H., Fujimura, T., Yamasaki, K., Aiba, S., & Asano, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010875 · Cited by 27
Ishizaka, S. T., Hawkins, L. D., Chen, Q., Tago, F., Yagi, T., Sakaniwa, K., Zhang, Z., Shimizu, T., & Shirato, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175962 · Cited by 26
Small molecule modulators of immune pattern recognition receptors
Tsukidate, T., Hespen, C. W., & Hang, H. C. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00096f · Cited by 28
Nishibayashi, R., Inoüe, R., Harada, Y., Watanabe, T., Makioka‐Itaya, Y., & Ushida, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129806 · Cited by 26
Sahingur, S. E., Xia, X., & Schifferle, R. E. (2011) · Journal of Periodontology · doi:10.1902/jop.2011.110522 · Cited by 28
DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects
Kwak, H., Lee, E., & Karki, R. (2024) · Immunological Reviews · doi:10.1111/imr.13382 · Cited by 27
Skrzeczyńska-Moncznik, J., Włodarczyk, A., Banaś, M., Kwitniewski, M., Zabieglo, K., Kapińska-Mrowiecka, M., Dubin, A., & Cichy, J. (2013) · Europe PMC (PubMed Central) · Cited by 29
Lupus pathobiology based on genomics
Saeed, M. (2016) · Immunogenetics · doi:10.1007/s00251-016-0961-7 · Cited by 26
Optimizing conventional DMARD therapy for Sjögren's syndrome
van der Heijden, E. H. M., Kruize, A. A., Radstake, T. R. D. J., & van Roon, J. A. G. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.003 · Cited by 25
Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer
Ayari, C., Besançon, M., Bergeron, A., LaRue, H., Bussières, V., & Fradet, Y. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1789-y · Cited by 25
Chloroquine: a brand-new scenario for an old drug
Eftekhari, R. B., Maghsoudnia, N., & Dorkoosh, F. A. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1716729 · Cited by 26
Repurposing Existing Drugs for the Treatment of COVID-19
Farne, H. A., Kumar, K., Ritchie, A. I., Finney, L., Johnston, S. L., & Singanayagam, A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-566fr · Cited by 26
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology
Altulea, D., Maassen, S., Baranov, M. V., & van den Bogaart, G. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab016 · Cited by 25
Alvarado, R., O’Brien, B. A., Tanaka, A., Dalton, J. P., & Donnelly, S. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.11.008 · Cited by 27
TLR9 induces colitis‑associated colorectal carcinogenesis by regulating NF‑κB expression levels
Luo, Q., Zeng, L., Tang, C., Zhang, Z., Chen, Y., & Zeng, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11971 · Cited by 24
Ferrière, A., Santa, P., Garreau, A., Bandopadhyay, P., Blanco, P., Ganguly, D., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624256 · Cited by 25
Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
Cao, X., Cordova, A. F., & Li, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00716 · Cited by 26
The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus
Lu, K., Wu, M.-Y., Wang, C., Wang, C., Chung, W., Chung, W., & Chen, C. (2019) · Cells · doi:10.3390/cells8101213 · Cited by 25
Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis
Faselis, C. J., Zeng‐Treitler, Q., Cheng, Y., Kerr, G. S., Nashel, D. J., Liappis, A. P., Weintrob, A., Karasik, P., Arundel, C., Boehm, D., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41803 · Cited by 23
Immunomodulatory Effects of Antimicrobial Drugs
Ruh, C. A., Banjade, R., Mandadi, S., Marr, C. M., Sumon, Z. E., & Crane, J. K. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1373900 · Cited by 25
Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
Shah, S. M. A., Rasheed, T., Rızwan, K., Bilal, M., Iqbal, H. M. N., Rasool, N., Toma, S. I., Marceanu, L. G., & Bobescu, E. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.12.023 · Cited by 22
Burel, S. A., Machemer, T., Baker, B. F., Kwoh, T. J., Paz, S., Younis, H. S., & Henry, S. P. (2022) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0033 · Cited by 23
New treatment options for lupus – a focus on belimumab
Chiche, L. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s19819 · Cited by 22
Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis
Yao, J., Xie, J., Xie, B., Li, Y., Jiang, L., Sui, X., Zhou, X., Pan, H., & Han, W. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.06.004 · Cited by 22
For whom the disc tolls: intervertebral disc degeneration, back pain and toll-like receptors
Bisson, D. G., Mannarino, M., Racine, R., & Haglund, L. (2021) · European Cells and Materials · doi:10.22203/ecm.v041a23 · Cited by 24
Minutolo, A., Petrone, V., Fanelli, M., Iannetta, M., Giudice, M., Belkacem, I. A., Zordan, M., Vitale, P., Rasi, G., Vallebona, P. S., et al. (2021) · Pathogens · doi:10.3390/pathogens10121639 · Cited by 25
Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects
Chang, J., & Werth, V. P. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1188006 · Cited by 21
Luo, X., Zhai, Z., Lin, Z., Wu, S., Xu, W., Li, Y., Zhuang, J., Li, J., Yang, F., & He, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110244 · Cited by 21
Cui, J., Hong, P., Li, Z., Lin, J., Wu, X., Nie, K., Zhang, X., & Wan, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110353 · Cited by 21
Metadata
- Authors
- Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R.
- Affiliations
- National Institute of Chemistry (SI)
- Blood Transfusion Centre of Slovenia (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04
- Volume
- 186
- Issue
- 8
- Pages
- 4794-4804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2118400571
- Cited by
- 606
- References
- 40
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 43 · 2023: 30 · 2022: 42 · 2021: 69 · 2020: 89 · 2019: 38 · 2018: 39 · 2017: 38 · 2016: 41 · 2015: 43 · 2014: 32 · 2013: 22 · 2012: 28
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- antimalarial drugs, imidazoquinolines, chloroquine, hydroxychloroquine, quinacrine, TLR8, R848, nucleic acid binding, endosomal acidification, TLR9, TLR3, TLR7/8 agonist, systemic lupus erythematosus, autoimmune disease therapy, propidium iodide, bafilomycin
- MeSH terms
- Animals, Antimalarials, Binding, Competitive, Cell Line, Cells, Cultured, Chloroquine, Culture Media, Humans, Hydrogen-Ion Concentration, Imidazoles, Nucleic Acids, Quinacrine, Quinolines, Endosomes, Transfection, Cytokines, Serum, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 7, Toll-Like Receptor 8, Toll-Like Receptor 9, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.